EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Metabolomics-Based Machine Learning for Predicting Mortality: Unveiling Multisystem Impacts on Health

Anniina Oravilahti iD, Jagadish Vangipurapu iD, Markku Laakso iD, Lilian Fernandes Silva iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms252111636 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Anniina Oravilahti und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, 70210 Kuopio, Finland. Hauptthemen laut MEDLINE: Machine Learning, Metabolomics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Academy of Finland, Centre of Excellence of Cardiovascular and Metabolic Diseases, Sigrid Juselius Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reliable predictors of long-term all-cause mortality are needed for middle-aged and older populations. Previous metabolomics mortality studies have limitations: a low number of participants and metabolites measured, measurements mainly using nuclear magnetic spectroscopy, and the use only of conventional statistical methods. To overcome these challenges, we applied liquid chromatography–tandem mass spectrometry and measured >1000 metabolites in the METSIM study including 10,197 men. We applied the machine learning approach together with conventional statistical methods to identify metabolites associated with all-cause mortality. The three independent machine learning methods (logistic regression, XGBoost, and Welch’s t-test) identified 32 metabolites having the most impactful associations with all-cause mortality (25 increasing and 7 decreasing the risk). From these metabolites, 20 were novel and encompassed various metabolic pathways, impacting the cardiovascular, renal, respiratory, endocrine, and central nervous systems. In the Cox regression analyses (hazard ratios and their 95% confidence intervals), clinical and laboratory risk factors increased the risk of all-cause mortality by 1.76 (1.60–1.94), the 25 metabolites by 1.89 (1.68–2.12), and clinical and laboratory risk factors combined with the 25 metabolites by 2.00 (1.81–2.22). In our study, the main causes of death were cancers (28%) and cardiovascular diseases (25%). We did not identify any metabolites associated with cancer but found 13 metabolites associated with an increased risk of cardiovascular diseases. Our study reports several novel metabolites associated with an increased risk of mortality and shows that these 25 metabolites improved the prediction of all-cause mortality beyond and above clinical and laboratory measurements.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Machine LearningMetabolomicsHumansMaleMiddle AgedAgedMortalityRisk FactorsMetabolomeTandem Mass SpectrometryBiomarkers

Stichwörter der Autor:innen

agingartificial intelligencemetabolismmetabolitesmortality

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland, 70210 Kuopio, Finland.
  • Department of Medicine, Kuopio University Hospital, 70200 Kuopio, Finland.
  • Department of Medicine, Division of Cardiology, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.

ORCID-Profile: Anniina Oravilahti, Jagadish Vangipurapu, Markku Laakso, Lilian Fernandes Silva

Förderung

  • Academy of Finland
  • Centre of Excellence of Cardiovascular and Metabolic Diseases
  • Sigrid Juselius Foundation
  • Finnish Foundation for Cardiovascular Research grant
  • Kuopio University Hospital grant
  • Innovative Medicines Initiative Joint Undertaking
  • Centre of Excellence of Cardiovascular and Metabolic Diseases, the Academy of Finland
  • Finnish Foundation for Cardiovascular Research

Zitieren

APA

Oravilahti, A., Vangipurapu, J., Laakso, M., & Fernandes Silva, L. (2024). Metabolomics-Based Machine Learning for Predicting Mortality: Unveiling Multisystem Impacts on Health. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111636

Vancouver

Oravilahti A, Vangipurapu J, Laakso M, Fernandes Silva L. Metabolomics-Based Machine Learning for Predicting Mortality: Unveiling Multisystem Impacts on Health. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111636

BibTeX
@article{Oravilahti2024,
  author = {Oravilahti, Anniina and Vangipurapu, Jagadish and Laakso, Markku and Fernandes Silva, Lilian},
  title = {Metabolomics-Based Machine Learning for Predicting Mortality: Unveiling Multisystem Impacts on Health},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms252111636}
}
Kostenlos starten →